Hunter's diseaseE76.1

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 31.07.2024

Dieser Artikel auf Deutsch

Synonym(s)

Hunter's disease; Hunter Syndrome

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Hunter, 1917

DefinitionThis section has been translated automatically.

Type II of hereditary mucopolysaccharidoses with iduronate sulfate sulfatase defect (mutation in the IDS gene).

Occurrence/EpidemiologyThis section has been translated automatically.

Incidence: 0.5-1/100,000 men/year.

EtiopathogenesisThis section has been translated automatically.

X-linked (recessive) inherited mutations of the iduronidase sulfatase gene (gene locus: Xq28). Due to the iduronidase sulfatase defect, the L-iduronic acid-containing mucopolysaccharides dermatan sulfate and heparan sulfate cannot be degraded or only insufficiently. They are deposited in the skin and in internal organs.

Clinical featuresThis section has been translated automatically.

Integument: Generalized, yellowish-whitish, hard plates caked to the base, usually from birth. Subsequent atrophy and sclerosis of the skin and skin appendages. Frequently pebble-like raised skin texture, acrocyanosis, hyperhidrosis pedum et manuum or hypertrichosis.

In some cases, image of Becker nevus with dorsal(Mongolian spot) or ventral distribution on the trunk.

Extracutaneous manifestations: dwarfism with dysostotic skeletal changes: coarse facial features, joint contractures, hepatosplenomegaly, mucopolysacchariduria. No corneal opacities. Cardiovascular symptoms are less frequent than in Pfaundler-Hurler disease.

LiteratureThis section has been translated automatically.

  1. Froissart R et al (2002) Mucopolysaccharidosis type II--genotype/phenotype aspects. Acta Paediatr Suppl 91: 82-87
  2. Hunter CA (1917) A rare disease in two brothers. Proceedings of the Royal Society of Medicine (London) 10: 104-116
  3. Keulemans JL et al. (2002) Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay. Prenat Diagn 22: 1016-1021
  4. Ochiai T et al. (2003) Significance of extensive Mongolian spots in Hunter's syndrome. Br J Dermatol 148: 1173-1178
  5. Sofronova V et al. (2023) A Case of Mucopolysaccharidosis II Caused by a Novel Variant with Skin Linear Hyperpigmented Streaks along Blaschko's Lines. Int J Mol Sci 24:5647.
  6. Tomanin R et al. (2002) Non-viral transfer approaches for the gene therapy of mucopolysaccharidosis type II (Hunter syndrome). Acta Paediatr Suppl 91: 100-104
  7. Zhang Z et al.(2023) Phenotypic and genetic characteristics of 130 patients with mucopolysaccharidosis type
  8. II: A single-center retrospective study in China. Front Genet 14:1103620.

Authors

Last updated on: 31.07.2024